España
Acceder
Cotización de Catalyst Pharmaceuticals, Inc. (CPRX) hoy en tiempo real
Análisis técnico y gráfico histórico de Catalyst Pharmaceuticals, Inc.
Análisis fundamental y estadísticas clave de Catalyst Pharmaceuticals, Inc.
Ficha de Catalyst Pharmaceuticals, Inc. (CPRX)
| Ticker | CPRX |
|---|---|
| ISIN | US14888U1016 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Catalyst Pharmaceuticals, Inc.
Resumen financiero e información corporativa de Catalyst Pharmaceuticals, Inc.
Ratios de valoración: PER, EV/EBITDA y métricas de Catalyst Pharmaceuticals, Inc.
Márgenes de rentabilidad y Cash Flow de Catalyst Pharmaceuticals, Inc.
BPA, Dividendos y Valor Contable: Métricas por acción de Catalyst Pharmaceuticals, Inc.
Solvencia y deuda: Análisis del balance de Catalyst Pharmaceuticals, Inc.
Ratios de liquidez y Test Ácido: Capacidad de pago de Catalyst Pharmaceuticals, Inc.
Invertir en Catalyst Pharmaceuticals, Inc. en 2026: Preguntas frecuentes
¿Qué es Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company also develops Firdapse for the treatment of MuSK antibody p...
¿En qué sector opera Catalyst Pharmaceuticals, Inc.?
Catalyst Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.